Global Crohn’s Disease Treatment Market: By Drug Class (Antibiotics, Anti-Diarrheal, Immune System Suppressants, Analgesics, Anti-Inflammatory Drugs, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Geogarphy


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global Crohn's Disease Treatment Market size valued at USD 800 Mn in 2021 and expected to reach USD 1088.7 Mn by 2028, at a CAGR of 4.5% during the forecast period 2022 to 2028. Crohn’s disease belongs to a condition called inflammatory bowel disease (IBD) that causes inflammation and damage to the digestive tract. Crohn’s disease usually affects at the end of small intestine and beginning of colon, but inflammation may occur anywhere along the digestive tract. Crohn’s disease may be hereditary or develop due to the malfunctioning of the immune system. Currently there is no cure for crohn's disease. However, there are many treatments to manage disease symptoms. Inflammation, ulcers, bowel obstruction, malnutrition, colon cancer, and anal fissures are some of the complications associated with the disease. Surgery and drug therapy are some of the treatment options available to treat Crohn’s disease. Some of the anti-inflammatory drugs used to treat crohn’s disease include, corticosteroids and oral 5-aminosalicylates. Global Crohn’s disease treatment market is expected to grow at a significant rate during the forecast period. Growth in biologics development unfolded the opportunities for the new market players as they are most commonly used in Crohn’s disease treatment. Market players are focusing on to develop new products that can treat Crohn’s disease. For instance, mongersen, is investigational therapy for the treatment of crohn’s disease, is being developed by Celgene Corporation in phase 3 clinical trials. Considering the foreseen factors Crohn’s disease treatment market is projected to have a lucrative opportunity for market players. Manufacturers of Crohn's disease medications are concentrating on commercial distribution through retail pharmacies and online portals. Anti-inflammatory medications and corticosteroids are routinely distributed through these channels, both with and without a prescription. Consumers might also get savings when buying drugs in bulk through online platforms. The substantial rise of the anti-inflammatory medications segment of the global Crohn's disease market is mostly due to easy product availability and price cuts.

Global Crohns Disease Treatment Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Crohns Disease Market Dynamics

The prime driver for global Crohn’s disease treatment market is increase in number of people being infected by the disease. In addition, increase in demand for biologics and high unmet needs within the anti-TNF refractory patient group that presents untapped market opportunities. Strong pipeline and novel mechanisms to treat Crohn’s disease are fueling the growth of global Crohn’s disease treatment market . However, patent expiry of the key drugs and high cost of treatment is expected to hamper the Crohn’s disease treatment market globally. High R&D investment for development of biological drugs and unknown etiology of the Crohn’s disease further hindering the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Crohns Disease Treatment Market Segmentation

Drug Class
  • Antibiotics
  • Anti-Diarrheal
  • Immune System Suppressants
  • Analgesics
  • Anti-Inflammatory Drugs
  • Monoclonal Antibodies
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Allergan, Inc. (U.S.)
  • AbbVie Inc., (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Bayer AG (Switzerland)
  • UCB S.A. (Belgium)
  • Perrigo Company plc (Ireland)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Services, Inc. (U.S)
  • Ferring B.V. (Switzerland)